Publikationen, an denen er mitarbeitet José María Pelayo Terán (17)

2024

  1. Health service and psychotropic medication use for mental health conditions among healthcare workers active during the Spain Covid-19 Pandemic – A prospective cohort study using web-based surveys.

    Psychiatry Research, Vol. 334

2023

  1. Traumatic stress symptoms among Spanish healthcare workers during the COVID-19 pandemic: a prospective study

    Epidemiology and psychiatric sciences, Vol. 32, pp. e50

2022

  1. Four-month incidence of suicidal thoughts and behaviors among healthcare workers after the first wave of the Spain COVID-19 pandemic

    Journal of Psychiatric Research, Vol. 149, pp. 10-17

  2. Mental impact of Covid-19 among Spanish healthcare workers. A large longitudinal survey

    Epidemiology and Psychiatric Sciences, Vol. 31

2021

  1. Mental health impact of the first wave of COVID-19 pandemic on Spanish healthcare workers: A large cross-sectional survey

    Revista de Psiquiatria y Salud Mental, Vol. 14, Núm. 2, pp. 90-105

  2. Thirty-day suicidal thoughts and behaviors among hospital workers during the first wave of the Spain COVID-19 outbreak

    Depression and Anxiety, Vol. 38, Núm. 5, pp. 528-544

  3. Thirty-day suicidal thoughts and behaviours in the Spanish adult general population during the first wave of the Spain COVID-19 pandemic

    Epidemiology and Psychiatric Sciences, Vol. 30

2011

  1. Insight dimensions in first-episode psychosis patients: Clinical, cognitive, pre-morbid and socio-demographic correlates

    Early Intervention in Psychiatry, Vol. 5, Núm. 2, pp. 140-149

2008

  1. 1-year follow-up study of cognitive function in first-episode non-affective psychosis

    Schizophrenia Research, Vol. 104, Núm. 1-3, pp. 165-174

  2. Cannabis abuse is associated with decision-making impairment among first-episode patients with schizophrenia-spectrum psychosis

    Psychological Medicine, Vol. 38, Núm. 9, pp. 1257-1266

  3. Effect of antipsychotic drugs on brain morphometry. A randomized controlled one-year follow-up study of haloperidol, risperidone and olanzapine

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 32, Núm. 8, pp. 1936-1943

  4. Epidemiological factors associated with treated incidence of first-episode non-affective psychosis in Cantabria: Insights from the Clinical Programme on Early Phases of Psychosis

    Early Intervention in Psychiatry, Vol. 2, Núm. 3, pp. 178-187

  5. Lack of association between clinical and cognitive change in first-episode psychosis: The first 6 weeks of treatment

    Canadian Journal of Psychiatry, Vol. 53, Núm. 12, pp. 839-847

  6. Lack of influence of COMT Val158Met genotype on cognition in first-episode non-affective psychosis

    Schizophrenia Research, Vol. 102, Núm. 1-3, pp. 206-209

  7. Pretreatment predictors of cognitive deficits in early psychosis

    Psychological Medicine, Vol. 38, Núm. 5, pp. 737-746

2007

  1. Cognitive dimensions in first-episode schizophrenia spectrum disorders

    Journal of Psychiatric Research, Vol. 41, Núm. 11, pp. 968-977

  2. Neuropsychological functioning and brain structure in schizophrenia

    International Review of Psychiatry, Vol. 19, Núm. 4, pp. 325-336